| Dr Richard Dean Maas, | |
|
2230 W Sunset St, Springfield, MO 65807-5980 | |
| (417) 730-2100 | |
| (417) 730-2119 |
| Full Name | Dr Richard Dean Maas |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist - Orthopedic |
| Location | 2230 W Sunset St, Springfield, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124656574 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2251X0800X | Physical Therapist - Orthopedic | 104753 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Dean Maas, 4254 S Mentor Ave, Springfield, MO 65804-6684 Ph: (417) 730-2012 | Dr Richard Dean Maas, 2230 W Sunset St, Springfield, MO 65807-5980 Ph: (417) 730-2100 |
News Archive
The goal of this research was to create an ECM modified hyaluronic acid (HA) based hydrogel culture system that allows for the growth and differentiation of salivary acinar cells into functional acini-like structures capable of secreting large amounts of protein and fluid unidirectionally. Xerostomia, a condition resulting from irradiation of the head and neck, affects more than 40,000 cancer patients each year in the United States. According to this research, these patients will greatly benefit from the development of a functional implantable artificial salivary gland.
Gas transfer is the best lung function predictor of survival in patients with chronic obstructive pulmonary disease, study results suggest.
Elixir Medical Corporation, a developer of product platforms that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE Mark approval for its DESyne BD Novolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that in collaboration with OXiGENE, Professor Gordon Rustin and colleagues from the Mount Vernon Cancer Research Centre, UK and other institutions in the United Kingdom, reported positive final data from an investigator-sponsored Phase 1 study of OXi4503 in patients with solid tumors.
› Verified 9 days ago
Mrs. Amy Alison Sanders, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2960 N Eastgate Ave, Springfield, MO 65803 Phone: 417-889-9773 | |
Matt Taylor, PT, DPT, CWS, WCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2017 W Woodland St, Springfield, MO 65807 Phone: 417-889-4800 Fax: 417-889-0980 | |
Mr. Stanley Lee Brown, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 902 W Battlefield St, Springfield, MO 65807 Phone: 417-886-6200 Fax: 417-886-6201 | |
Carla Williams, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3545 S National Ave, Springfield, MO 65807 Phone: 417-269-9682 Fax: 417-269-5508 | |
Mrs. Erin Michelle Kirsch, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 639 W Chestnut Expy, Springfield, MO 65802 Phone: 417-523-7500 Fax: 417-523-7595 | |
Ronald Lee Sapp I, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3545 S National Ave, Springfield, MO 65807 Phone: 417-875-3125 Fax: 417-269-5508 | |
Dr. Tamra Holmes Standage, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2900 S National Ave Ste A, Springfield, MO 65804 Phone: 417-269-8355 Fax: 417-269-8854 |